Director Wang Shaomeng details Ascentage Pharma (AAPG) shares, options, RSUs

Rhea-AI Filing Summary

ASCENTAGE PHARMA GROUP INTERNATIONAL director Wang Shaomeng filed an initial ownership report showing a mix of direct and indirect stakes in the company’s Ordinary Shares, along with equity awards in the form of options and restricted share units.

Direct holdings include 1,193,032 Ordinary Shares, options over 17,965 Ordinary Shares at an exercise price of $8.14 per share expiring on November 26, 2035, and 27,965 restricted share units, each convertible into one Ordinary Share and scheduled to vest annually on November 26 of 2026, 2027, 2028 and 2029. Additional Ordinary Shares are held indirectly through trusts, with 2,836,845 shares held by KEW Trust and 6,024,066 shares held by Shaomeng Wang Dynasty Trust.

Insider Trade Summary

5 transactions reported

Mixed 5 txns

Insider Wang Shaomeng

Role Director

Type	Security	Shares	Price	Value
holding	Options	--	--	--
holding	Restricted share units	--	--	--
holding	Ordinary Shares	--	--	--
holding	Ordinary Shares	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Options — 17,965 shares (Direct); Restricted share units — 27,965 shares (Direct); Ordinary Shares — 1,193,032 shares (Direct); Ordinary Shares — 2,836,845 shares (Indirect, See Footnote (1))

Footnotes (1)

1. Held by KEW Trust. Held by Shaomeng Wang Dynasty Trust. The stock options vest in twelve (12) tranches equally on the 26th of the month starting November 26, 2025. The exercise price for the stock options is in HKD, and the exercise price included in the table represents conversion to USD based on the exchange rate on the date of grant. Each restricted stock unit (RSUs) represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on each of 11/26/2026, 2027, 2028 and 2029.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Wang Shaomeng

(Last) (First) (Middle)

700 KING FARM BLVD, STE 510

(Street)

ROCKVILLE MARYLAND 20850

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
ASCENTAGE PHARMA GROUP INTERNATIONAL [ AAPG ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	1,193,032	D
Ordinary Shares	2,836,845	I	See Footnote (1)(1)
Ordinary Shares	6,024,066	I	See Footnote (2)(2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options	(3)	11/26/2035	Ordinary Shares	17,965	$8.14(4)	D
Restricted share units	(5)	(5)	Ordinary Shares	27,965	$0	D

Explanation of Responses:

1. Held by KEW Trust.

2. Held by Shaomeng Wang Dynasty Trust.

3. The stock options vest in twelve (12) tranches equally on the 26th of the month starting November 26, 2025.

4. The exercise price for the stock options is in HKD, and the exercise price included in the table represents conversion to USD based on the exchange rate on the date of grant.

5. Each restricted stock unit (RSUs) represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on each of 11/26/2026, 2027, 2028 and 2029.

Remarks:

This form is filed using a special power of attorney.

	Thomas J. Knapp	03/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)